Seres Therapeutics (MCRB) Institutional Ownership $18.94 -0.05 (-0.26%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$19.11 +0.17 (+0.92%) As of 08/29/2025 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Seres Therapeutics (NASDAQ:MCRB)CurrentInstitutional OwnershipPercentage59.34%Number ofInstitutional Buyers(last 12 months)18TotalInstitutional Inflows(last 12 months)$57.70MNumber ofInstitutional Sellers(last 12 months)10TotalInstitutional Outflows(last 12 months)$42.93M Get MCRB Insider Trade Alerts Want to know when executives and insiders are buying or selling Seres Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data MCRB Institutional Buying and Selling by Quarter Seres Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Bridgeway Capital Management LLC12,500$139K0.0%-95.0%0.143% 8/13/2025 Marshall Wace LLP91,405$1.02M0.0%N/A1.045% 8/12/2025 XTX Topco Ltd22,417$249K0.0%N/A0.256% 8/8/2025 Geode Capital Management LLC91,602$1.02M0.0%-94.3%1.049% 8/8/2025 SBI Securities Co. Ltd.3,482$39K0.0%-95.0%0.040% 7/23/2025 Vontobel Holding Ltd.80,325$892K0.0%-92.6%0.920% 6/27/2025 Goldman Sachs Group Inc.74,629$52K0.0%+40.9%0.855% 5/16/2025 Goldman Sachs Group Inc.74,629$52K0.0%+40.9%0.855% 5/12/2025 Invesco Ltd.136,572$96K0.0%+193.2%1.564% 5/9/2025 Charles Schwab Investment Management Inc.834,107$584K0.0%-3.7%9.568% Get the Latest News and Ratings for MCRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Seres Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/2/2025 SBI Securities Co. Ltd.69,664$49K0.0%+221.8%0.799% 4/28/2025 Vontobel Holding Ltd.1,085,966$760K0.0%+15.7%12.457% 2/17/2025 Millennium Management LLC1,810,719$1.51M0.0%+77.2%1.061% 2/17/2025 Cantor Fitzgerald L. P.95,740$80K0.0%-65.9%0.056% 2/14/2025 Jane Street Group LLC58,736$49K0.0%+181.4%0.034% 2/14/2025 Schonfeld Strategic Advisors LLC100,700$84K0.0%-76.8%0.059% 2/14/2025 Northern Trust Corp262,683$218K0.0%+20.4%0.154% 2/12/2025 Geode Capital Management LLC1,510,432$1.26M0.0%+8.8%0.885% 2/11/2025 LPL Financial LLC94,787$79K0.0%-22.4%0.056% 2/10/2025 Avantax Advisory Services Inc.45,179$38K0.0%+170.9%0.026% 2/6/2025 Charles Schwab Investment Management Inc.865,825$720K0.0%+15.6%0.507% 1/30/2025 Vontobel Holding Ltd.938,295$780K0.0%+137.6%0.550% 1/17/2025 Janney Montgomery Scott LLC48,500$40K0.0%-29.8%0.028% 11/20/2024 Virtu Financial LLC58,791$56K0.0%+44.8%0.034% 11/16/2024 Geode Capital Management LLC1,388,639$1.31M0.0%+22.5%0.816% 11/15/2024 State Street Corp383,248$363K0.0%+12.9%0.225% 11/15/2024 Point72 Asia Singapore Pte. Ltd.44,972$43K0.0%-64.8%0.026% 11/14/2024 Providence Wealth Advisors LLC98,500$93K0.1%+29.2%0.058% 11/13/2024 FMR LLC22,857,260$21.63M0.0%+0.6%13.430% 11/12/2024 Charles Schwab Investment Management Inc.748,718$708K0.0%+42.4%0.440% 10/16/2024 Vontobel Holding Ltd.394,826$374K0.0%N/A0.261% 9/16/2024 Point72 DIFC Ltd87,754$64K0.0%N/A0.058% 9/16/2024 Point72 Asia Singapore Pte. Ltd.127,634$92K0.0%N/A0.084% 8/15/2024 Point72 Asia Singapore Pte. Ltd.127,634$92K0.0%N/A0.084% 8/14/2024 Point72 DIFC Ltd87,754$64K0.0%N/A0.058% 8/9/2024 Providence Wealth Advisors LLC76,250$58K0.0%+49.5%0.050% 8/1/2024 Rhumbline Advisers55,112$40K0.0%-61.0%0.036% 5/20/2024 Virtu Financial LLC94,510$73K0.0%N/A0.062% 5/15/2024 Price T Rowe Associates Inc. MD298,111$232K0.0%-18.0%0.197% 5/10/2024 Vanguard Group Inc.6,734,821$5.21M0.0%+12.1%4.460% “Sell Nvidia before earnings” (Ad)Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.See Eric’s full analysis and get all 7 free trade ideas here5/1/2024 BNP Paribas Financial Markets46,549$36K0.0%-19.8%0.031% 5/1/2024 Mirae Asset Global Investments Co. Ltd.50,102$39K0.0%N/A0.033% 2/14/2024 Pennant Investors LP292,300$409K0.1%N/A0.226% 2/13/2024 Tower Research Capital LLC TRC38,091$53K0.0%+668.6%0.029% 2/1/2024 Handelsbanken Fonder AB1,100,000$1.54M0.0%+10.0%0.851% 1/24/2024 Clear Creek Financial Management LLC26,950$38K0.0%-47.6%0.021% 1/12/2024 SG Americas Securities LLC52,080$73K0.0%N/A0.040% 12/7/2023 Hudson Bay Capital Management LP1,999,800$4.76M0.0%+127.3%1.547% 11/22/2023 Graham Capital Management L.P.206,838$492K0.0%+731.3%0.160% 11/14/2023 Corton Capital Inc.23,245$55K0.0%-64.7%0.018% 11/14/2023 Profund Advisors LLC155,798$371K0.0%+11.9%0.121% 11/13/2023 Federated Hermes Inc.8,981,717$21.38M0.1%-21.2%6.949% 11/13/2023 Dark Forest Capital Management LP117,498$280K0.0%N/A0.091% 11/13/2023 Aigen Investment Management LP75,241$179K0.0%+577.1%0.058% 11/13/2023 FMR LLC19,230,692$45.77M0.0%+0.2%14.878% 11/13/2023 Rafferty Asset Management LLC936,382$2.23M0.0%+21.1%0.724% 11/7/2023 Quantbot Technologies LP50,400$120K0.0%N/A0.039% 11/7/2023 Barclays PLC461,209$1.10M0.0%+24.3%0.360% 10/30/2023 Arete Wealth Advisors LLC24,900$59K0.0%+99.2%0.019% 10/23/2023 Commonwealth Equity Services LLC11,040$26K0.0%N/A0.009% 10/19/2023Simplicity Solutions LLC11,294$27K0.0%N/A0.009% 10/11/2023 Vontobel Holding Ltd.17,000$40K0.0%-52.6%0.013% 8/14/2023 Great Point Partners LLC938,067$4.49M0.9%N/A0.732% 8/14/2023 UniSuper Management Pty Ltd415,292$1.99M0.0%N/A0.324% 8/14/2023 Parallax Volatility Advisers L.P.134,901$646K0.0%N/A0.105% 8/14/2023 Graham Capital Management L.P.24,881$119K0.0%N/A0.019% 8/11/2023 Natixis99,000$474K0.0%N/A0.077% 8/11/2023 E Fund Management Co. Ltd.41,581$199K0.0%+206.1%0.032% 8/11/2023 ExodusPoint Capital Management LP594,895$2.85M0.0%N/A0.464% 8/10/2023 Profund Advisors LLC139,249$667K0.0%+210.4%0.109% 8/9/2023 BNP Paribas Arbitrage SNC154,663$741K0.0%+61.9%0.121% 8/7/2023 Principal Financial Group Inc.45,205$217K0.0%+21.5%0.035% 8/4/2023 American International Group Inc.46,820$224K0.0%+37.7%0.037% 8/3/2023 Jennison Associates LLC1,392,356$6.67M0.0%+109.5%1.089% 8/2/2023 Handelsbanken Fonder AB1,000,000$4.79M0.0%+25.0%0.782% 7/31/2023 LPL Financial LLC115,058$551K0.0%+20.3%0.090% 7/31/2023 Alpha DNA Investment Management LLC138,536$664K0.2%N/A0.108% 7/28/2023 Mach 1 Financial Group LLC94,961$455K0.1%N/A0.074% 7/26/2023 Janney Montgomery Scott LLC90,285$432K0.0%-11.7%0.071% 7/25/2023Raymond James & Associates10,052$48K0.0%N/A0.008% 7/24/2023 Vontobel Holding Ltd.35,865$172K0.0%+74.6%0.028% 7/21/2023 Creative Planning17,304$83K0.0%N/A0.014% 7/19/2023 Teacher Retirement System of Texas27,360$131K0.0%-10.9%0.021% 7/18/2023 Diversified Trust Co10,000$48K0.0%N/A0.008% 7/17/2023 Clear Creek Financial Management LLC54,200$260K0.0%N/A0.042% 7/14/2023 Aries Wealth Management18,000$86K0.0%+50.0%0.014% 7/13/2023 Cambridge Investment Research Advisors Inc.44,844$215K0.0%N/A0.035% 7/10/2023 AE Wealth Management LLC95,188$456K0.0%N/A0.074% 7/7/2023 Auour Investments LLC17,000$81K0.0%N/A0.013% 5/16/2023 Avoro Capital Advisors LLC1,295,000$7.34M0.1%N/A1.013% One tiny company just cracked Google’s $19B problem (Ad)For decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. Then an MIT team cracked the code… dropping the cost from $63,000 to just 90 cents per gram. Now, one US-based factory is gearing up to supply the AI, aerospace, and EV industries with the one material they can’t continue to grow without. Only one company controls it, and its stock is still flying under Main Street’s radar.See why the race for supply has already started.5/15/2023 Atom Investors LP90,388$512K0.3%-5.4%0.071% 5/12/2023 Profund Advisors LLC44,859$254K0.0%N/A0.035% 5/11/2023 PFG Investments LLC20,500$116K0.0%N/A0.016% 5/11/2023 FMR LLC18,911,458$107.23M0.0%+1.2%14.794% 5/11/2023 Knott David M Jr315,000$1.79M0.7%+57.4%0.246% 5/11/2023 E Fund Management Co. Ltd.13,585$77K0.0%-18.5%0.011% 5/10/2023 Oppenheimer & Co. Inc.37,111$210K0.0%N/A0.029% 5/10/2023 Simplify Asset Management Inc.550,626$3.12M0.4%N/A0.431% 5/8/2023 Federated Hermes Inc.15,277,356$86.62M0.2%-15.5%11.951% 5/8/2023 Zurcher Kantonalbank Zurich Cantonalbank24,010$136K0.0%+39.0%0.019% (Data available from 1/1/2016 forward) MCRB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MCRB shares? During the previous two years, 46 institutional investors and hedge funds held shares of Seres Therapeutics. The most heavily invested institutionals were FMR LLC ($21.63M), Federated Hermes Inc. ($21.38M), Vanguard Group Inc. ($5.21M), Hudson Bay Capital Management LP ($4.76M), Rafferty Asset Management LLC ($2.23M), Handelsbanken Fonder AB ($1.54M), and Millennium Management LLC ($1.51M).Learn more on Seres Therapeutics' institutional investors. What percentage of Seres Therapeutics' stock is owned by institutional investors? 59.34% of Seres Therapeutics' stock is owned by institutional investors. Learn more on MCRB's institutional investor holdings. Which institutional investors have been buying Seres Therapeutics' stock? Of the 35 institutional investors that purchased Seres Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Hudson Bay Capital Management LP ($1.12M), Vontobel Holding Ltd. ($1.09M), Millennium Management LLC ($788.76K), Vanguard Group Inc. ($729.51K), Geode Capital Management LLC ($376.81K), Charles Schwab Investment Management Inc. ($339.88K), and Pennant Investors LP ($292.30K). How much institutional buying is happening at Seres Therapeutics? Institutional investors have bought a total of 3,437,053 shares in the last 24 months. This purchase volume represents approximately $57.70M in transactions. Which of Seres Therapeutics' major shareholders have been selling company stock? Of the 10 institutional investors that sold Seres Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Geode Capital Management LLC ($1.53M), Vontobel Holding Ltd. ($1.01M), Schonfeld Strategic Advisors LLC ($333.20K), Bridgeway Capital Management LLC ($237.50K), Cantor Fitzgerald L. P. ($184.83K), Point72 Asia Singapore Pte. Ltd. ($82.66K), and SBI Securities Co. Ltd. ($66.18K). How much institutional selling is happening at Seres Therapeutics? Institutional investors have sold a total of 3,516,934 shares in the last 24 months. This volume of shares sold represents approximately $42.93M in transactions. Related Companies GHRS Institutional Ownership KALV Institutional Ownership KURA Institutional Ownership SIGA Institutional Ownership BCAX Institutional Ownership VIR Institutional Ownership RLAY Institutional Ownership KROS Institutional Ownership MGTX Institutional Ownership MRVI Institutional Ownership This page (NASDAQ:MCRB) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seres Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Seres Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MCRB Stock Alerts